Ivani novato Silva

Dr. Ivani novato Silva

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
CCCristiane de Freitas Cunha
Cristiane de Freitas Cunha
ISIvani novato Silva
Ivani novato Silva
FFFrancisca Lee Finch
Francisca Lee Finch
The duration of glucocorticoid-induced inhibition that occurs in the hypothalamic-pituitary-adrenal (HPA) axis after discontinuation of treatment is controversial. The main objective of this prospective study was to evaluate the inhibition of the HPA axis by dexamethasone in children and adolescents with acute lymphoid leukemia. Thirty-five patients (median age of 6.9 yr) were evaluated. A stimulus test with ovine CRH (1 microg/kg) was performed before the introduction of dexamethasone (6 mg/m2.d for 28 d), in the 8th and 28th days of glucocorticoid therapy, and 48 h and 1 month after discontinuation of glucocorticoid therapy. Suppression of the basal secretion as well as the maximum concentration of ACTH occurred during glucocorticoid therapy (P < 0.01). The pituitary function before the introduction of dexamethasone was similar to the one seen 48 h and 1 month after withdrawing it. Suppression of the adrenal function was detected during glucocorticoid therapy, which persisted for 48 h after the steroid was removed from treatment (P < 0.01). One month after ceasing the administration of the glucocorticoid, the adrenal function was similar to that before glucocorticoid therapy. According to these results, a clinical and laboratory follow-up of the HPA axis in the month after the cessation of dexamethasone therapy is suggested to determine glucocorticoid replacement.

1 February 2006 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
MTMariella Guarino Tanure
Mariella Guarino Tanure
ISIvani novato Silva
Ivani novato Silva
MBMagda Bahia
Magda Bahia
FPFrancisco José Penna
Francisco José Penna

1 December 2015 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
TRTânia Maria Barreto Rodrigues
Tânia Maria Barreto Rodrigues
CBCristina Botelho Barra
Cristina Botelho Barra
JSJovita Lane Soares Santos
Jovita Lane Soares Santos
EGEugênio Marcos Andrade Goulart
Eugênio Marcos Andrade Goulart
AFAdaliene Ferreira
Adaliene Ferreira
ISIvani novato Silva
Ivani novato Silva
Key words: Adrenal hyperplasia, congenital; risk factors; carotid intima-media thickness; overweight; hypertension

1 April 2009 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
AXAndréa Cristina Vilan Xavier
Andréa Cristina Vilan Xavier
ISIvani novato Silva
Ivani novato Silva
FCFernando de Oliveira Costa
Fernando de Oliveira Costa
DCDaniela Soares Corrêa
Daniela Soares Corrêa
OBJETIVO: Avaliar a condição periodontal de crianças e adolescentes diabéticos e fatores relacionados. MÉTODOS: O índice de placa (IPL), sítios com sangramento à sondagem (SS), profundidade de sondagem (PS) e nível de inserção clínica (NIC) foram avaliados em todos os dentes permanentes em oclusão de 168 diabéticos tipo 1, não fumantes, com 13 ± 3,5 anos de idade. IPL e SS foram avaliados também em dentes decíduos. RESULTADOS: Observou-se prevalência de 20,8% de gengivite e 5,9% de periodontite. Indivíduos com mau controle metabólico tiveram maiores percentuais de sítios com alteração da PS (p = 0,004) e NIC (p = 0,014). Indivíduos com > 5 anos de doença apresentaram maiores percentuais de sítios afetados à avaliação da PS (p = 0,002), NIC (p = 0,007) e SS (p < 0,001). CONCLUSÕES: Maior duração do diabetes melito tipo 1 e mau controle metabólico foram significativamente associados a alterações periodontais indicando maior suscetibilidade para doença periodontal nessa população.

1 May 2014 in Jornal de Pediatria
Verified
Journal Article
Open access
IPIsabela L. Pezzuti
Isabela L. Pezzuti
CBCristina B. Barra
Cristina B. Barra
RMRafael M. Mantovani
Rafael M. Mantovani
JJJosé N. Januário
José N. Januário
ISIvani novato Silva
Ivani novato Silva
Congenital adrenal hyperplasia (CAH) newborn screening can prevent neonatal mortality in children with the salt-wasting form of the disease and prevent incorrect gender assignments, which can occur in females. However, the occurrence of false-positive results in preterm or low-birth-weight newborns creates some diagnostic difficulties, with consequent therapeutic implications. This study aimed to report the results of a pilot project for neonatal CAH screening conducted in the state of Minas Gerais, Brazil from 09/2007 to 05/2008 with a three-year follow-up. dried blood specimens were collected on filter paper cards three to seven days after birth of all newborns in the period. Samples were analyzed for 17-hydroxyprogesterone using an enzyme-linked immunosorbent assay (ELISA). a total of 159,415 children were screened. The apparent incidence of the classic variant of the disease was 1:9,963, based on initial diagnoses following newborn screening. During the follow-up period, eight of 16 children initially diagnosed with CAH were reclassified as unaffected, resulting in a revised incidence of 1:19,927. The false-positive rate was 0.31%, and the positive predictive value was 2.1%. Sensitivity and specificity were 100% and 99.7%, respectively. newborn screening is an important public health policy in developing countries such as Brazil, where CAH remains underdiagnosed. It has great potential to identify children with the disease who otherwise cannot be diagnosed earlier. Long-term follow-up and monitoring of all children with positive screening results are crucial to ensure a correct diagnosis and to calculate a reliable incidence ratio of the disease.

1 December 2019 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
JZJovita Lane Soares Santos Zanini
Jovita Lane Soares Santos Zanini
TRTânia Maria Barreto Rodrigues
Tânia Maria Barreto Rodrigues
CBCristina Botelho Barra
Cristina Botelho Barra
MFMaria Francisca Tereza Freire Filgueiras
Maria Francisca Tereza Freire Filgueiras
ISIvani novato Silva
Ivani novato Silva
Objective: To contribute to the assessment of normal parameters of carotid intima-media thickness (CIMT) in healthy adolescents. Methods: A cross-sectional study was conducted through clinical, laboratory and ultrasound evaluation in 61 healthy adolescents. The inclusion criteria consisted of being in good health. The exclusion criteria were: presence or history of any chronic disease; being obese or overweight according to the World Health Organization (WHO) established criterion; continuous use of medication; or presenting a febrile condition or requiring medication within 48-hours prior to assessment. The pubertal stages were evaluated using the Tanner criteria. The high-resolution B-mode ultrasound examinations were performed according to the recommendations of the Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Results: Adolescents were 14±2.6 years old, 62.3% female, 19 (31%) at early puberty (Tanner II and III), and 38 (62%) at late puberty (Tanner IV and V). They presented normal clinical and laboratorial parameters. CIMT values were 0.46±0.04 to 0.55±0.04 mm on the right and 0.48±0.02 to 0.53±0.04 mm on the left, according to pubertal maturation. CIMT values increased significantly on the right and left sides, according to pubertal stage (p<0.001 and p=0.016), and maximum internal diameters of the common carotid artery (p<0.025 and p<0.003). It was higher in males compared to females. Conclusions: An increase in CIMT in the healthy adolescents group, according to both age, and the degree of pubertal maturation should be considered when evaluating adolescents in diagnostic procedures.